RecruitingNot Applicable

Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair

Germany200 participantsStarted 2020-11-30

Plain-language summary

The Pforzheim Tricuspid Valve Registry study is designed to confirm the safety and performance of the TriClip™ device in a contemporary real-world setting in critically ill patients. The observational trial is a prospective, single arm, open-label, single-center, post market registry.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects (\>=18 years age) have severe tricuspid regurgitation and are symptomatic despite medical therapy. * Subjects eligible to receive the TriClip™ * Subjects must provide written informed consent prior to study procedure. Exclusion Criteria: * Subjects participating in another clinical study that may impact the follow-up or results of this study.

What they're measuring

Procedural Success

Timeframe: at 12 months

Trial details

NCT IDNCT05179616

SponsorHelios Klinikum Pforzheim

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-11-30

Contact for this trial

Ilka Ott, MD, PhD

+4972319692955 Ilka.Ott@helios-pforzheim.de

View on ClinicalTrials.gov More Tricuspid Regurgitation trials